Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study

Lauri Burroughs; Eneida Nemecek; Troy Torgerson; Katherine A. Guthrie; Julie-An Talano; Jennifer Domm; Akiko Shimamura; Paul A. Carpenter; Suzanne Skoda-Smith; Janet A. Englund; K. Scott Baker; Rainer F. Storb; Ann Woolfrey

doi:10.1016/j.bbmt.2012.11.119

Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2012.11.119 ◽

2013 ◽

Vol 19 (2) ◽

pp. S158

Author(s):

Lauri Burroughs ◽

Eneida Nemecek ◽

Troy Torgerson ◽

Katherine A. Guthrie ◽

Julie-An Talano ◽

...

Keyword(s):

Cell Transplantation ◽

Phase Ii ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Malignant Diseases ◽

Preliminary Results

Download Full-text

A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation

Haematologica ◽

10.3324/haematol.2012.067140 ◽

2012 ◽

Vol 97 (12) ◽

pp. 1882-1889 ◽

Cited By ~ 53

Author(s):

J. Pidala ◽

J. Kim ◽

H. Jim ◽

M. A. Kharfan-Dabaja ◽

T. Nishihori ◽

...

Keyword(s):

Cell Transplantation ◽

Phase Ii ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Randomized Phase Ii

Download Full-text

Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2015.05.018 ◽

2015 ◽

Vol 21 (10) ◽

pp. 1770-1775 ◽

Cited By ~ 28

Author(s):

Moshe Yeshurun ◽

Ofer Shpilberg ◽

Corina Herscovici ◽

Liat Shargian ◽

Juliet Dreyer ◽

...

Keyword(s):

Cell Transplantation ◽

Phase Ii ◽

Graft Versus Host Disease ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Host Disease ◽

Graft Versus Host

Download Full-text

Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2015.12.028 ◽

2016 ◽

Vol 22 (4) ◽

pp. 705-709 ◽

Cited By ~ 60

Author(s):

Brian C. Shaffer ◽

Jean-Benoit Le Luduec ◽

Christopher Forlenza ◽

Ann A. Jakubowski ◽

Miguel-Angel Perales ◽

...

Keyword(s):

Natural Killer Cell ◽

Natural Killer ◽

Cell Transplantation ◽

Phase Ii ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Killer Cell ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Myeloid Malignancies

Download Full-text

A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation

American Journal of Hematology ◽

10.1002/ajh.25035 ◽

2018 ◽

Vol 93 (4) ◽

pp. E96-E98

Author(s):

Dipenkumar Modi ◽

Zaid Al-Kadhimi ◽

Wei Chen ◽

Hyejeong Jang ◽

Abhinav Deol ◽

...

Keyword(s):

Cell Transplantation ◽

Phase Ii ◽

Graft Versus Host Disease ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Host Disease ◽

Graft Versus Host ◽

Related Donor

Download Full-text

Reduced Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma – a Phase II Study

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00283-9 ◽

2021 ◽

Vol 27 (3) ◽

pp. S228-S229

Author(s):

Carl T. Shultz ◽

Chelby Wakefield ◽

Steven Rollins ◽

Sijin Wen ◽

Lauren Veltri ◽

...

Keyword(s):

Cell Transplantation ◽

Phase Ii ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Once Daily ◽

Refractory Lymphoma ◽

Reduced Toxicity

Download Full-text

Early Results of a Phase II Study Adding Peri-Transplant Rituximab to Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients (PTS) with High-Risk Fludarabine-Refractory Chronic Lymphocytic Leukemia (Cll)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2011.12.505 ◽

2012 ◽

Vol 18 (2) ◽

pp. S289-S290

Author(s):

M.L. Sorror ◽

B. Storer ◽

B.M. Sandmaier ◽

T. Chauncey ◽

B. Bruno ◽

...

Keyword(s):

High Risk ◽

Chronic Lymphocytic Leukemia ◽

Cell Transplantation ◽

Phase Ii ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Lymphocytic Leukemia ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Early Results

Download Full-text

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study

Haematologica ◽

10.3324/haematol.2011.059378 ◽

2012 ◽

Vol 97 (10) ◽

pp. 1523-1531 ◽

Cited By ~ 75

Author(s):

B. Federmann ◽

M. Bornhauser ◽

C. Meisner ◽

L. Kordelas ◽

D. W. Beelen ◽

...

Keyword(s):

Cell Transplantation ◽

Phase Ii ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Reduced Intensity Conditioning ◽

Reduced Intensity

Download Full-text

Favorable Preliminary Results Using TLI/ATG-Based Pre-Transplant Conditioning for Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Pediatric Severe Aplastic Anemia

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2010.12.091 ◽

2011 ◽

Vol 17 (2) ◽

pp. S182-S183

Author(s):

A. Pillai ◽

C. Hartford ◽

C. Wang ◽

D. Pei ◽

J. Yang ◽

...

Keyword(s):

Aplastic Anemia ◽

Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Severe Aplastic Anemia ◽

Unrelated Donor ◽

Matched Unrelated Donor ◽

Preliminary Results

Download Full-text

Adding peri-transplant rituximab to nonmyeloablative (NMA) conditioning before allogeneic hematopoietic cell transplantation (allo-HCT) to improve disease-related outcomes in patients with chronic lymphocytic leukemia (CLL): Phase II clinical trial.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.7052 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 7052-7052

Author(s):

Mazyar Shadman ◽

Mohamed L Sorror ◽

Brenda M. Sandmaier ◽

Barry Storer ◽

Thomas R. Chauncey ◽

...

Keyword(s):

Clinical Trial ◽

Chronic Lymphocytic Leukemia ◽

Cell Transplantation ◽

Phase Ii ◽

Hematopoietic Cell Transplantation ◽

Lymphocytic Leukemia ◽

Hematopoietic Cell ◽

Phase Ii Clinical Trial ◽

Allogeneic Hematopoietic Cell Transplantation

Download Full-text

Health Care Utilization and Cost of Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Children with Malignant and Non-Malignant Diseases

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2017.12.509 ◽

2018 ◽

Vol 24 (3) ◽

pp. S427 ◽

Cited By ~ 1

Author(s):

Angela Ricci ◽

Zhezhen Jin ◽

Wallace Bourgeois ◽

Monica Bhatia ◽

Diane George ◽

...

Keyword(s):

Health Care ◽

Health Care Utilization ◽

Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Care Utilization ◽

Malignant Diseases

Download Full-text